Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04386681 · ClinicalTrials.gov registry record · NA
Re-entry Continuum for Brain Injury
A NA study of Traumatic Brain Injury and Recidivism, sponsored by Rehabilitation Hospital of Indiana.
- Active
- Registry status
- NA
- Development phase
- 102
- Enrollment target
- 1
- Study location
NCT04386681: Active NA study of Traumatic Brain Injury and Recidivism, sponsored by Rehabilitation Hospital of Indiana.
NCT04386681 is a NA study of Traumatic Brain Injury and Recidivism that is active but no longer recruiting, run by Rehabilitation Hospital of Indiana. The registered enrollment target is 102 participants, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04386681, a NA study of Traumatic Brain Injury and Recidivism, is active but no longer recruiting, sponsored by Rehabilitation Hospital of Indiana.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 102 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall research objectives of the proposed project are to decrease the rate of recidivism, defined as returning to incarceration within three years of release, as well as reduce the number of violent offenses, through the successful implementation of a continuum of services that addresses the unique needs of the TBI population. RHI, in partnership with PCF and IU, will work together to accomplish these goals. To meet study objectives, this randomized controlled trial (RCT) will enroll 102 individuals with TBI who will be randomized into the Reentry Continuum for Brain Injury (RCBI) intervention or a TAU-CG. Participants will be screened for TBI eight months prior to release from PCF. Upon consenting to participate, all subjects will be evaluated before, during, and after the intervention and recidivism data will be collected through IDOC's Data Analysis and Technology Department.
Primary Outcome
Designed to measure self-efficacy related to brain injury. BICS-Q was designed based on Bandura's Guide for developing self-efficacy scales. Participants rate 20 items using a 5-point Likert-scale resulting in a total score. BICS-Q has shown significant change across BICS participants in multiple studies. Participants rate each statement from 0 (Not at all) to 4 (Extremely). Higher scores suggest greater self-efficacy.
Conditions Studied
Interventions
- BEHAVIORAL Reentry Continuum for Brain Injury (RCBI)
Study Locations (1)
Indiana
- Putnamville Correctional Facility - Greencastle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2021-03-01 |
| Est. Completion | 2027-01-01 |
| Phase | NA |
What the registry record for NCT04386681 still lists
NCT04386681 is an interventional study that assigns participants to a tested intervention. The registered 102 participants enrollment target is mid-sized for trials with a published cap, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (63% lower).
The record links to 2 conditions, with Traumatic Brain Injury appearing as the primary indexed condition, and to 1 intervention - of which Reentry Continuum for Brain Injury (RCBI) is the first listed.
NCT04386681 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT04386681 about?
NCT04386681 is a clinical study titled "Re-entry Continuum for Brain Injury". The overall research objectives of the proposed project are to decrease the rate of recidivism, defined as returning to incarceration within three years of release, as well as reduce the number of violent offenses, through the successful implementation of a continuum of services that addresses the u...
What is the current status of trial NCT04386681?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 102 participants. The study started on 2021-03-01. Estimated completion is 2027-01-01.
What conditions does trial NCT04386681 study?
This clinical trial studies the following conditions: Traumatic Brain Injury, Recidivism.
What interventions are being tested in trial NCT04386681?
The interventions under investigation include: Reentry Continuum for Brain Injury (RCBI) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04386681?
This trial is sponsored by Rehabilitation Hospital of Indiana, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04386681 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Traumatic Brain Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04386681's enrollment target sits among peer trials
102 69th of 171 higher than 103 of 171 other Traumatic Brain Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Traumatic Brain Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
tPBM in Older Adults With Traumatic Brain Injury
RECRUITING · NA
-
Carbon Dioxide Administration and Brain Waste Clearance
RECRUITING · NA
-
TMS-fNIRS Personalized Dosing
RECRUITING · NA
-
Community-based Implementation of Online EmReg
RECRUITING · NA
-
Evaluation of the Abbott i-STAT TBI Biomarker Test
RECRUITING · NA
-
Long-term Brain Stimulation of the Motor Ventral Thalamus (VOP/VIM) to Improve Motor Function
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03704662 · 102 participants · NA
Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma
- NCT04174742 · 102 participants
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer
- NCT04275362 · 102 participants
Gait Analysis of a Lateral-Pivot Design Total Knee Replacement
- NCT04541082 · 102 participants · Phase 1
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI